Live Breaking News & Updates on Edward Holson

Stay updated with breaking news from Edward holson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Photys Therapeutics Debuts with $75 Million Series A Funding to Advance New Class of Bifunctional Mo

- Phosphorylation-inducing chimeric small molecules (PHICS) are a new class of bifunctional medicines that direct and repair aberrant and dysfunctional proteins- PHICS enable precise phosphorylation, an important post-translational modification that controls protein function, including activation, stabilization, tra. ....

United States , Salk Institute , Dan Nomura , Wendy Young , Renato Dulbecco , Eli Lilly , Tony Hunter , Brian Fenton , Angela Koehler , Briggs Morrison , Amit Choudhary , David Steinberg , Otello Stampacchia , Eric Fischer , Edward Holson , Luke Evnin , Arkin Bio , Lizzie Ngo , University Of California , Broad Institute , Koch Institute , Syndax Pharmaceuticals , Swanson Biotechnology Center High , Merck Co , University Of Massachusetts , Worcester Polytechnic Institute ,

Photys Therapeutics Raises $75M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

United States , Eli Lilly , Brian Fenton , Edward Holson , Luke Evnin , Briggs Morrison , Arkin Bio , Amit Choudhary , Otello Stampacchia , Lizzie Ngo , Broad Institute , Syndax Pharmaceuticals , Ventures Fund , Longwood Fund Principal , Longwood Fund , Photys Therapeutics , Omega Funds , Mass General Brigham Ventures , Heritage Medical , Chief Scientific Officer Edward Holson , Phosphorylation Inducing Chimeric Small Molecules , Managing Director , Alon Lazarus , Investment Manager , Executive Partner ,

Photys Therapeutics raises $75M in Series A funds to control disease-causing proteins

Photys Therapeutics has debuted with a $75 million Series A funding round. The startup focuses on phosphorylation-inducing chimeric small molecules (PHICS) a new class of bifunctional medicines that can direct and repair protein phosphorylation. ....

United States , Arkin Bio , Amit Choudhary , Eli Lilly , Lizzie Ngo , Edward Holson , Broad Institute , Ventures Fund , Longwood Fund , Omega Funds , Mass General Brigham Ventures , Heritage Medical , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens ,